Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Exploring how meditation affects pain relief in patients with chronic low back pain on opioids

Official title: Neural Mechanisms of Meditation-Based Interventions for Chronic Low Back Pain

Run by University of Utah · NCT05607381 · Data updated 2026-11-12

This study tests whether mindfulness meditation can help people with chronic low back pain who are taking opioids feel less pain.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment188 (estimated)
SponsorUniversity of Utah
Academic / other
Locations2 sites (La Jolla, California and 1 other locations)
StatusRecruiting
StartedNovember 30, 2022
Main results expectedApril 30, 2027
Study endsJune 30, 2027
Registry record updatedJuly 27, 2026
Trial IDNCT05607381 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 with chronic low back pain who have been using prescription opioids for at least three months.

Probably not a fit

Patients with prior extensive meditation training or those with certain medical conditions, such as current cancer diagnosis or severe mental health issues, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates the impact of a mindfulness meditation-based intervention on pain relief in patients suffering from chronic low back pain who are currently using opioid medications. The study aims to uncover the neural mechanisms involved in pain relief through meditation, utilizing brain imaging techniques to assess changes in brain activity. Participants will engage in meditation practices alongside their usual care to evaluate the effectiveness of this approach in managing their pain.

Why it matters

Potential benefit: If successful, this intervention could provide a non-pharmacological method for managing chronic low back pain, potentially reducing reliance on opioids.

How similar studies have gone: Other studies have shown promising results in using mindfulness meditation for pain management, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1\) men/women 18-65 years of age; 2) current chronic low back pain classified according to the NIH Pain Consortium task force research standards for chronic low back pain (pain on at least half the days in the past 6 months); usual back pain ≥3 on 0-10 scale with opioid medication; and 4) current use of prescription opioids for ≥3 months.

Exclusion Criteria:

1\) Prior experience with MBSR, MBCT, MORE, or extensive involvement in any standardized meditation training, 2) current cancer diagnosis, 3) suicide intent or attempt in the past 30 days, 4) psychosis or moderate/severe non-opioid substance use disorder in past 6 months; 5) persons with any electronic objects or certain metal objects in their head or body that are incompatible with MRI; 6) those who have had an abnormal brain MRI in the past; 7) those unable to lie still on their back for 1 to 1.5 hours; and 8) pregnancy.

Where it's running

  • University of California, San Diego
    La Jolla, California, United States
    Recruiting
  • Center on Mindfulness and Integrative Health Intervention Development
    Salt Lake City, Utah, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.